BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29772439)

  • 1. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
    Li Z; Yang L; Liu X; Nie Z; Luo J
    Biomed Pharmacother; 2018 Aug; 104():181-192. PubMed ID: 29772439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Noncoding RNA MEG3 and its Target miR-147 Regulate JAK/STAT Pathway in Advanced Chronic Myeloid Leukemia.
    Li ZY; Yang L; Liu XJ; Wang XZ; Pan YX; Luo JM
    EBioMedicine; 2018 Aug; 34():61-75. PubMed ID: 30072211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia.
    Li Z; Luo J
    Biochem Biophys Res Commun; 2018 Jun; 501(1):64-72. PubMed ID: 29704505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275.
    Yang JR; Shi MX; Zeng Y
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2103-2111. PubMed ID: 30915755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
    Liu Z; Chen JY; Zhong Y; Xie L; Li JS
    Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia.
    Wen F; Cao YX; Luo ZY; Liao P; Lu ZW
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):1-8. PubMed ID: 30366670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia.
    Lu Y; Li Y; Chai X; Kang Q; Zhao P; Xiong J; Wang J
    Gene; 2017 Apr; 607():41-46. PubMed ID: 28069548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
    Ji L; Li X
    J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis.
    Zhang X; Wu N; Wang J; Li Z
    J Cell Mol Med; 2019 Oct; 23(10):6708-6719. PubMed ID: 31328388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.
    Zhang X; Yang L; Liu X; Nie Z; Wang X; Pan Y; Luo J
    Br J Haematol; 2017 Sep; 178(5):728-738. PubMed ID: 28480959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
    Wang X; Li X; Wang Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
    Long J; Pi X
    Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
    Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.
    Zhang L; Liang X; Li Y
    Oncol Rep; 2017 Oct; 38(4):2408-2416. PubMed ID: 28791407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer.
    Xu G; Meng L; Yuan D; Li K; Zhang Y; Dang C; Zhu K
    Oncol Rep; 2018 Jul; 40(1):39-48. PubMed ID: 29749532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA-MEG3 promotes bovine myoblast differentiation by sponging miR-135.
    Liu M; Li B; Peng W; Ma Y; Huang Y; Lan X; Lei C; Qi X; Liu GE; Chen H
    J Cell Physiol; 2019 Aug; 234(10):18361-18370. PubMed ID: 30887511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
    Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
    J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.